Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF).

Yamamoto N, Ushijima N, Koga Y.

J Med Virol. 2009 Jan;81(1):16-26. doi: 10.1002/jmv.21376. Retraction in: J Med Virol. 2014 Nov;86(11):1998.

2.

Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.

Yamamoto N, Suyama H, Nakazato H, Yamamoto N, Koga Y.

Cancer Immunol Immunother. 2008 Jul;57(7):1007-16. Retraction in: Cancer Immunol Immunother. 2014 Dec;63(12):1349.

3.
4.
5.

Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice.

Koga Y, Naraparaju VR, Yamamoto N.

Proc Soc Exp Biol Med. 1999 Jan;220(1):20-6.

PMID:
9893164
8.

Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus.

Yamamoto N, Urade M.

Microbes Infect. 2005 Apr;7(4):674-81. Epub 2005 Mar 22.

PMID:
15848273
9.

Structural modification of serum vitamin D3-binding protein and immunosuppression in AIDS patients.

Yamamoto N, Naraparaju VR, Srinivasula SM.

AIDS Res Hum Retroviruses. 1995 Nov;11(11):1373-8.

PMID:
8573395
10.

Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation.

Mohamad SB, Nagasawa H, Uto Y, Hori H.

Comp Biochem Physiol A Mol Integr Physiol. 2002 May;132(1):1-8.

PMID:
12062184
11.
12.

GC protein-derived macrophage-activating factor decreases α-N-acetylgalactosaminidase levels in advanced cancer patients.

Thyer L, Ward E, Smith R, Branca JJ, Morucci G, Gulisano M, Noakes D, Eslinger R, Pacini S.

Oncoimmunology. 2013 Aug 1;2(8):e25769. Epub 2013 Jul 29.

14.

Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients.

Yamamoto N, Naraparaju VR, Asbell SO.

Cancer Res. 1996 Jun 15;56(12):2827-31.

15.
17.

Oleic Acid, deglycosylated vitamin D-binding protein, nitric oxide: a molecular triad made lethal to cancer.

Ruggiero M, Ward E, Smith R, Branca JJ, Noakes D, Morucci G, Taubmann M, Thyer L, Pacini S.

Anticancer Res. 2014 Jul;34(7):3569-78.

PMID:
24982371
18.
20.

Oral Colostrum Macrophage-activating Factor for Serious Infection and Chronic Fatigue Syndrome: Three Case Reports.

Inui T, Kubo K, Kuchiike D, Uto Y, Nishikata T, Sakamoto N, Mette M.

Anticancer Res. 2015 Aug;35(8):4545-9.

PMID:
26168499
Items per page

Supplemental Content

Write to the Help Desk